Boehringer, Amneal Strike Deal To End Aggrenox Patent Row
Boehringer Ingelheim Pharmaceuticals Inc. on Monday agreed to dismiss its New Jersey federal suit accusing Amneal Pharmaceuticals LLC of patent infringement over its generic version of stroke-prevention drug Aggrenox, saying they...To view the full article, register now.
Already a subscriber? Click here to view full article